TABLE 2.
MULTIVARIATE ANALYSIS OF PROGNOSTIC FACTORS
| Progression-Free Survival
|
Overall Survival
|
|||||
|---|---|---|---|---|---|---|
| Prognostic Factor | HR | (95% CI) | p-value | HR | (95% CI) | p-value |
| Age (years) | ||||||
| ≤ 40 | Referent | Referent | ||||
| 41–50 | 0.87 | (0.57–1.31) | 0.496 | 0.76 | (0.49–1.17) | 0.210 |
| 51–60 | 0.57 | (0.34–0.94) | 0.027 | 0.56 | (0.34–0.95) | 0.031 |
| > 60 | 0.90 | (0.57–1.42) | 0.640 | 0.93 | (0.58–1.50) | 0.767 |
| Race | ||||||
| Caucasian | Referent | Referent | ||||
| African American | 1.09 | (0.74–1.61) | 0.657 | 0.90 | (0.60–1.36) | 0.623 |
| Other | 0.49 | (0.29–0.82) | 0.007 | 0.42 | (0.24–0.74) | 0.003 |
| Peformance Status | ||||||
| 0 | Referent | Referent | ||||
| 1 or 2 | 1.04 | (0.73–1.49) | 0.835 | 1.06 | (0.73–1.53) | 0.766 |
| Histology | ||||||
| Squamous | Referent | Referent | ||||
| Non-Squamous | 1.40 | (0.89–2.21) | 0.147 | 1.32 | (0.81–2.16) | 0.261 |
| FIGO Stage | ||||||
| II | Referent | Referent | ||||
| III/IV | 1.88 | (1.34–2.63) | <0.001 | 1.98 | (1.39–2.81) | <0.001 |
| Tumor Grade | ||||||
| 1 or 2 | Referent | Referent | ||||
| 3 | 1.81 | (1.30–2.54) | <0.001 | 2.01 | (1.42–2.85) | <0.001 |
| Tumor Size (cm) | ||||||
| < 6.0 | Referent | Referent | ||||
| ≤6.0 | 1.24 | (0.86–1.79) | 0.247 | 1.14 | (0.78–1.67) | 0.501 |
HR: Hazard Ratio; CI: 95% Confidence Interval.
HR, CI and p-value reported from Cox model.